Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

BANAMINE DIN 00465305

Status: Marketed
Holder: INTERVET CANADA CORP
Molecule: FLUNIXIN (FLUNIXIN MEGLUMINE)
Available to quote

Health Canada record

Active ingredient(s)FLUNIXIN (FLUNIXIN MEGLUMINE) 50 MG
Dosage formSolution
RouteIntramuscular; Intravenous
SchedulePRESCRIPTION
ClassVeterinary
ATC
Original market date31-Dec-1979
Current status date12-Jan-2012
SourceHealth Canada DPD

Establishment licence of the holder

Intervet Canada Corp. — licence 100147, currently licensed, last inspection rating C (2023-07-17).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing FLUNIXIN (FLUNIXIN MEGLUMINE)

DINProductCompanyFormStrengthStatus
02457180BANAMINEINTERVET CANADA CORPSolutionFLUNIXIN (FLUNIXIN MEGLUMINE) 50 MGMarketed
02240510FLUNAZINEBIMEDA-MTC ANIMAL HEALTH INCSolutionFLUNIXIN (FLUNIXIN MEGLUMINE) 50 MGMarketed
02563584FLUTREXINMODERN VETERINARY THERAPEUTICS LLCSolutionFLUNIXIN (FLUNIXIN MEGLUMINE) 50 MGMarketed
02550474SOLNIXONBIMEDA-MTC ANIMAL HEALTH INCSolutionFLUNIXIN (FLUNIXIN MEGLUMINE) 50 MGMarketed
02234061SOLVEZINENORBROOK LABORATORIES LTD.SolutionFLUNIXIN (FLUNIXIN MEGLUMINE) 50 MGMarketed
00465291BANAMINE GRANULESSCHERING-PLOUGH CANADA INCGranulesFLUNIXIN (FLUNIXIN MEGLUMINE) 25 MGCancelled Post Market
02231381CITATION INJECTIONBAYER INC., ANIMAL HEALTHLiquidFLUNIXIN (FLUNIXIN MEGLUMINE) 50 MGCancelled Post Market
02230652CRONYXIN INJECTIONCROSS VETPHARM GROUP LTDSolutionFLUNIXIN (FLUNIXIN MEGLUMINE) 50 MGCancelled Post Market
02239149INFLUX-50 (FLUNIXIN MEGLUMINE INJECTION) STERILE INJECTABLE SOLUTIONVETOQUINOL N A INCSolutionFLUNIXIN (FLUNIXIN MEGLUMINE) 50 MGCancelled Post Market
02248807SUPPRESSORNORBROOK LABORATORIES LTD.SolutionFLUNIXIN (FLUNIXIN MEGLUMINE) 50 MGCancelled Post Market
02478951VETONIXINNORBROOK LABORATORIES LTD.SolutionFLUNIXIN (FLUNIXIN MEGLUMINE) 50 MGDormant

Notices of Compliance

NOCDateSubmissionReason
101862009-05-01New Drug Submission (NDS)Change in ownership
98152008-10-09Supplement to a New Drug Submission (SNDS)ADDITIONAL CLAIM
92392007-12-12Supplement to a New Drug Submission (SNDS)ALTERNATE SOURCE OF ACTIVE INGREDIENT
84712006-12-19Supplement to a New Drug Submission (SNDS)NEW INDICATION
36242003-01-06Supplement to a New Drug Submission (SNDS)ADDITIONAL SPECIES: CATTLE
Request a quote for BANAMINE

How to read a Canadian DIN record